Skip to main content
T&R Biofab Co., Ltd logo

T&R Biofab Co., Ltd — Investor Relations & Filings

Ticker · 246710 ISIN · KR7246710008 KO Manufacturing
Open in API
Filings indexed 416 across all filing types
Latest filing 2021-02-09 Regulatory Filings
Country KR South Korea
Listing KO 246710

About T&R Biofab Co., Ltd

http://www.tnrbiofab.com/en/

T&R Biofab Co., Ltd. is a biomedical engineering company specializing in the development and commercialization of regenerative medical technologies. The company utilizes its proprietary 3D bioprinting technology to manufacture a range of products. Its primary offerings include 3D-printed, bioresorbable medical scaffolds designed to aid in the regeneration and reconstruction of tissues and organs. Other key business areas encompass bio-surgical solutions, the development of organoids and mini-tissues for research and therapeutic applications, and the use of human induced pluripotent stem cells (hiPSC).

Recent filings

Filing Released Lang Actions
기타경영사항(특허권취득)(자율공시)(METHOD AND APPARATUS FOR MANUFACTURING PRINTOUT HAVING CROSS-SECTIONAL PATTERN)
Regulatory Filings Classification · 97% confidence The document is a voluntary disclosure (자율공시) regarding the acquisition of a patent by T&R Biofab. It details the patent name, content, and utilization plan. Since it is a regulatory announcement regarding a specific corporate event (patent acquisition) that does not fit into financial reporting, M&A, or governance categories, it falls under the general regulatory filing category.
2021-02-09 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (FSS) and the Korea Exchange. It details the share ownership and changes in holdings (specifically stock options exercised) by a company director (Kim Young-pil) of TNR Biofab. This type of filing is a standard regulatory disclosure for insider trading or changes in ownership by company insiders, which falls under the 'Director's Dealing' category.
2020-12-17 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory notice regarding the suspension of share registration (closing of the shareholder register) for the purpose of determining shareholders eligible to vote at the 8th Annual General Meeting. It is a standard regulatory announcement regarding corporate administrative procedures rather than a full report or a proxy statement itself. Given it does not fit into specific categories like dividend announcements or share issues, it falls under the general regulatory filing category.
2020-12-11 Korean
기타경영사항(특허권취득)(자율공시)(간 오가노이드 및 이의 제조방법)
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure ('자율공시') regarding the acquisition of a patent ('특허권 취득') by the company T&R Biofab. It details the patent name, content, and utilization plan. Since this is a regulatory announcement regarding a specific corporate event that does not fall into financial reporting, M&A, or governance categories, it is classified as a general regulatory filing.
2020-12-10 Korean
기타경영사항(특허권취득)(자율공시)(동결보관 및 저산소 조건에서의 생존율을 향상시키는 심근세포 응집체 제작 기술)
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure (자율공시) regarding the acquisition of a patent (특허권 취득) by T&R Biofab. It details the patent name, content, and future utilization plans. Since this is a regulatory announcement of a specific corporate event that does not fall into the categories of financial reports, shareholder meetings, or management changes, it is classified as a general regulatory filing.
2020-12-02 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details the share transactions (specifically a sale of shares) by an executive (Kim Seong-geun) of TNR Biofab. This type of filing is a standard regulatory disclosure for insider trading/director dealings in the Korean market, which corresponds to the 'Director's Dealing' category.
2020-11-27 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.